SIMILAR PATTERNS OF AMINO ACIDS FOR 1HXB_A_ROCA100_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bg4 ENDO-1,4-BETA-XYLANA
SE


(Penicillium
simplicissimum)
PF00331
(Glyco_hydro_10)
5 GLY A  19
ASP A   7
GLY A  78
ILE A  81
ILE A  37
None
GOL  A 630 (-3.5A)
None
None
None
0.88A 1hxbA-1bg4A:
undetectable
1hxbA-1bg4A:
15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
5 GLY A  40
ALA A  39
ASP A  38
ILE A  44
ILE A 328
None
0.88A 1hxbA-1fobA:
undetectable
1hxbA-1fobA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gae D-GLYCERALDEHYDE-3-P
HOSPHATE
DEHYDROGENASE


(Escherichia
coli)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA O  19
VAL O   3
ILE O 325
ILE O  11
ILE O  27
None
None
None
NAD  O 336 (-3.9A)
None
0.86A 1hxbA-1gaeO:
undetectable
1hxbA-1gaeO:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gom ENDO-1,4-BETA-XYLANA
SE


(Thermoascus
aurantiacus)
PF00331
(Glyco_hydro_10)
5 GLY A  19
ASP A   7
GLY A  77
ILE A  80
ILE A  36
None
0.87A 1hxbA-1gomA:
undetectable
1hxbA-1gomA:
15.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.82A 1hxbA-1hvcA:
14.0
1hxbA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
VAL A  32
GLY A  48
ILE A  84
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.71A 1hxbA-1hvcA:
14.0
1hxbA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.47A 1hxbA-1hvcA:
14.0
1hxbA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  48
GLY A  49
ILE A  50
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
0.45A 1hxbA-1hvcA:
14.0
1hxbA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.1A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.47A 1hxbA-1hvcA:
14.0
1hxbA-1hvcA:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  48
GLY A  49
PRO A  81
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.7A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.45A 1hxbA-1hvcA:
14.0
1hxbA-1hvcA:
48.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j2q PROTEASOME BETA
SUBUNIT


(Archaeoglobus
fulgidus)
PF00227
(Proteasome)
5 ALA H  38
ILE H 101
GLY H 102
GLY H 103
ILE H 104
None
0.85A 1hxbA-1j2qH:
undetectable
1hxbA-1j2qH:
18.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  84
None
0.50A 1hxbA-1q9pA:
10.5
1hxbA-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
VAL A  32
PRO A  81
ILE A  84
None
0.67A 1hxbA-1q9pA:
10.5
1hxbA-1q9pA:
93.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r6b CLPA PROTEIN

(Escherichia
coli)
PF00004
(AAA)
PF02861
(Clp_N)
PF07724
(AAA_2)
PF10431
(ClpB_D2-small)
5 GLY X 406
ALA X 405
ILE X 433
ILE X 399
ILE X 426
None
None
None
ADP  X 780 (-4.7A)
None
0.88A 1hxbA-1r6bX:
undetectable
1hxbA-1r6bX:
9.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
None
1.36A 1hxbA-1sivA:
18.5
1hxbA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.52A 1hxbA-1sivA:
18.5
1hxbA-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tye INTEGRIN BETA-3

(Homo sapiens)
PF00362
(Integrin_beta)
PF17205
(PSI_integrin)
5 GLY B 154
ALA B 155
GLY B 221
GLY B 222
ILE B 226
None
0.84A 1hxbA-1tyeB:
undetectable
1hxbA-1tyeB:
13.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xat XENOBIOTIC
ACETYLTRANSFERASE


(Pseudomonas
aeruginosa)
PF00132
(Hexapep)
5 GLY A  68
ALA A  69
ILE A 137
GLY A 138
ILE A  65
None
0.73A 1hxbA-1xatA:
undetectable
1hxbA-1xatA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xiw IMMUNOGLOBULIN HEAVY
CHAIN VARIABLE
REGION
T-CELL SURFACE
GLYCOPROTEIN CD3
EPSILON CHAIN


(Homo sapiens;
Mus musculus)
PF07686
(V-set)
PF16681
(Ig_5)
5 ASP D 104
GLY D 103
ILE A  45
GLY A  46
GLY A  47
None
0.86A 1hxbA-1xiwD:
undetectable
1hxbA-1xiwD:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y56 HYPOTHETICAL PROTEIN
PH1363


(Pyrococcus
horikoshii)
PF07992
(Pyr_redox_2)
PF13510
(Fer2_4)
5 ALA A 476
ILE A 316
GLY A 321
GLY A 320
ILE A 480
None
0.83A 1hxbA-1y56A:
undetectable
1hxbA-1y56A:
12.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yp4 GLUCOSE-1-PHOSPHATE
ADENYLYLTRANSFERASE
SMALL SUBUNIT


(Solanum
tuberosum)
PF00483
(NTP_transferase)
5 GLY A 358
ALA A 359
ILE A 408
GLY A 409
ILE A 355
None
0.76A 1hxbA-1yp4A:
undetectable
1hxbA-1yp4A:
13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ash QUEUINE
TRNA-RIBOSYLTRANSFER
ASE


(Thermotoga
maritima)
PF01702
(TGT)
5 ASP A 142
GLY A  92
GLY A 242
ILE A 214
ILE A 182
None
None
EDO  A 404 ( 4.5A)
EDO  A 404 (-4.0A)
None
0.87A 1hxbA-2ashA:
undetectable
1hxbA-2ashA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.69A 1hxbA-2bc0A:
undetectable
1hxbA-2bc0A:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dws COPPER-CONTAINING
NITRITE REDUCTASE


(Rhodobacter
sphaeroides)
PF00394
(Cu-oxidase)
PF07732
(Cu-oxidase_3)
5 GLY A 347
ALA A 348
ILE A 210
ILE A  99
PRO A 280
None
0.85A 1hxbA-2dwsA:
undetectable
1hxbA-2dwsA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fko 173AA LONG
HYPOTHETICAL
FERRIPYOCHELIN
BINDING PROTEIN


(Pyrococcus
horikoshii)
PF00132
(Hexapep)
5 ALA A  89
ILE A  74
GLY A  75
GLY A  92
ILE A 103
None
0.79A 1hxbA-2fkoA:
undetectable
1hxbA-2fkoA:
21.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  54
GLY A  55
PRO A  86
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.52A 1hxbA-2fmbA:
15.2
1hxbA-2fmbA:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.77A 1hxbA-2isqA:
undetectable
1hxbA-2isqA:
15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oqh PUTATIVE ISOMERASE

(Streptomyces
coelicolor)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 GLY A  48
ILE A  97
GLY A 275
GLY A 276
ILE A 277
None
0.84A 1hxbA-2oqhA:
undetectable
1hxbA-2oqhA:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.83A 1hxbA-2q0lA:
undetectable
1hxbA-2q0lA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q50 GLYOXYLATE
REDUCTASE/HYDROXYPYR
UVATE REDUCTASE


(Homo sapiens)
PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
5 GLY A  72
VAL A  63
ILE A  78
GLY A  54
ILE A  67
None
0.87A 1hxbA-2q50A:
undetectable
1hxbA-2q50A:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qkx BIFUNCTIONAL PROTEIN
GLMU


(Mycobacterium
tuberculosis)
PF00132
(Hexapep)
PF12804
(NTP_transf_3)
5 GLY A 334
ALA A 335
ILE A 366
GLY A 367
ILE A 331
None
0.73A 1hxbA-2qkxA:
undetectable
1hxbA-2qkxA:
15.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qzw CANDIDAPEPSIN-1

(Candida
albicans)
PF00026
(Asp)
5 ASP A  32
GLY A  34
ASP A  37
GLY A  83
ILE A 123
None
0.68A 1hxbA-2qzwA:
7.4
1hxbA-2qzwA:
14.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rik TITIN

(Oryctolagus
cuniculus)
PF07679
(I-set)
5 GLY A 175
VAL A 127
ILE A 119
GLY A 120
GLY A 121
None
0.86A 1hxbA-2rikA:
undetectable
1hxbA-2rikA:
18.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.46A 1hxbA-2rkfA:
21.0
1hxbA-2rkfA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.28A 1hxbA-2rspA:
13.1
1hxbA-2rspA:
32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x58 PEROXISOMAL
BIFUNCTIONAL ENZYME


(Rattus
norvegicus)
PF00378
(ECH_1)
PF00725
(3HCDH)
PF02737
(3HCDH_N)
5 GLY A  72
VAL A  28
GLY A  60
GLY A 100
ILE A  29
None
None
COA  A 760 ( 4.0A)
GOL  A 770 ( 4.3A)
None
0.69A 1hxbA-2x58A:
undetectable
1hxbA-2x58A:
8.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xvg ALPHA XYLOSIDASE

(Cellvibrio
japonicus)
PF01055
(Glyco_hydro_31)
PF16338
(DUF4968)
PF17137
(DUF5110)
5 ILE A 211
GLY A 186
GLY A 676
ILE A 675
ILE A 417
None
0.76A 1hxbA-2xvgA:
undetectable
1hxbA-2xvgA:
7.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zxh TRNA URIDINE
5-CARBOXYMETHYLAMINO
METHYL MODIFICATION
ENZYME MNMG


(Aquifex
aeolicus)
PF01134
(GIDA)
PF13932
(GIDA_assoc)
5 GLY A 389
ILE A  52
GLY A  53
GLY A  58
ILE A  59
None
0.84A 1hxbA-2zxhA:
undetectable
1hxbA-2zxhA:
9.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bn6 LACTADHERIN

(Bos taurus)
PF00754
(F5_F8_type_C)
5 GLY A   6
VAL A 138
GLY A  72
ILE A  74
ILE A  62
None
0.70A 1hxbA-3bn6A:
undetectable
1hxbA-3bn6A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c2o NICOTINATE-NUCLEOTID
E PYROPHOSPHORYLASE


(Saccharomyces
cerevisiae)
PF01729
(QRPTase_C)
PF02749
(QRPTase_N)
5 GLY A 141
ALA A 140
GLY A 258
GLY A 257
ILE A 274
None
0.85A 1hxbA-3c2oA:
undetectable
1hxbA-3c2oA:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ce9 GLYCEROL
DEHYDROGENASE


(Clostridium
acetobutylicum)
PF13685
(Fe-ADH_2)
5 ALA A 102
ASP A 101
GLY A  96
GLY A  95
ILE A  94
PEG  A 404 ( 4.7A)
None
EDO  A 401 ( 3.8A)
None
None
0.71A 1hxbA-3ce9A:
undetectable
1hxbA-3ce9A:
15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cj8 2,3,4,5-TETRAHYDROPY
RIDINE-2,6-DICARBOXY
LATE
N-ACETYLTRANSFERASE


(Enterococcus
faecalis)
PF00132
(Hexapep)
PF08503
(DapH_N)
PF14602
(Hexapep_2)
5 GLY A 112
ALA A 113
ILE A 145
GLY A 146
ILE A 109
None
0.84A 1hxbA-3cj8A:
undetectable
1hxbA-3cj8A:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cj8 2,3,4,5-TETRAHYDROPY
RIDINE-2,6-DICARBOXY
LATE
N-ACETYLTRANSFERASE


(Enterococcus
faecalis)
PF00132
(Hexapep)
PF08503
(DapH_N)
PF14602
(Hexapep_2)
5 GLY A 130
ALA A 131
ILE A 171
GLY A 172
ILE A 127
None
0.75A 1hxbA-3cj8A:
undetectable
1hxbA-3cj8A:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dj4 BIFUNCTIONAL PROTEIN
GLMU


(Mycobacterium
tuberculosis)
PF00132
(Hexapep)
PF12804
(NTP_transf_3)
5 GLY A 334
ALA A 335
ILE A 366
GLY A 367
ILE A 331
None
0.81A 1hxbA-3dj4A:
undetectable
1hxbA-3dj4A:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g7r PUTATIVE
TRANSCRIPTIONAL
REGULATOR


(Streptomyces
coelicolor)
PF00440
(TetR_N)
5 GLY A 166
ALA A 167
VAL A  99
GLY A 186
ILE A  98
None
None
None
None
EDO  A 960 ( 4.8A)
0.72A 1hxbA-3g7rA:
undetectable
1hxbA-3g7rA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hx1 SLR1951 PROTEIN

(Synechocystis
sp. PCC 6803)
PF00498
(FHA)
5 GLY A  83
VAL A 110
ILE A  44
GLY A  35
ILE A 102
None
0.72A 1hxbA-3hx1A:
undetectable
1hxbA-3hx1A:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kci PROBABLE E3
UBIQUITIN-PROTEIN
LIGASE HERC2


(Homo sapiens)
PF00415
(RCC1)
5 GLY A4099
ALA A4098
ILE A3991
GLY A3992
GLY A3993
None
0.64A 1hxbA-3kciA:
undetectable
1hxbA-3kciA:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kkj AMINE OXIDASE,
FLAVIN-CONTAINING


(Pseudomonas
syringae group
genomosp. 3)
PF01593
(Amino_oxidase)
PF13450
(NAD_binding_8)
5 GLY A  54
ALA A  55
ILE A  12
GLY A  11
GLY A  38
FAD  A 401 (-3.7A)
FAD  A 401 (-3.5A)
None
FAD  A 401 (-2.9A)
None
0.85A 1hxbA-3kkjA:
undetectable
1hxbA-3kkjA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l0i DRRA

(Legionella
pneumophila)
PF14860
(DrrA_P4M)
5 GLY A 411
ALA A 412
GLY A 463
ILE A 405
ILE A 471
None
0.88A 1hxbA-3l0iA:
undetectable
1hxbA-3l0iA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans)
PF05572
(Peptidase_M43)
5 ALA A 209
ASP A 207
VAL A 175
ILE A  82
ILE A 205
None
0.81A 1hxbA-3lunA:
undetectable
1hxbA-3lunA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdo PUTATIVE
PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Parabacteroides
distasonis)
PF02769
(AIRS_C)
5 GLY A  58
ASP A 160
ILE A 107
GLY A 108
ILE A  80
None
None
ACT  A 395 (-4.3A)
None
None
0.84A 1hxbA-3mdoA:
undetectable
1hxbA-3mdoA:
15.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
PRO A  81
None
0.89A 1hxbA-3mwsA:
19.6
1hxbA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
0.61A 1hxbA-3mwsA:
19.6
1hxbA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  48
GLY A  49
ILE A  50
ILE A  84
None
0.41A 1hxbA-3mwsA:
19.6
1hxbA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  48
GLY A  49
PRO A  81
ILE A  84
None
0.44A 1hxbA-3mwsA:
19.6
1hxbA-3mwsA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ogz UDP-SUGAR
PYROPHOSPHORYLASE


(Leishmania
major)
PF01704
(UDPGP)
5 GLY A 122
ALA A 121
ASP A 271
ILE A 269
ILE A 167
None
0.77A 1hxbA-3ogzA:
undetectable
1hxbA-3ogzA:
10.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.60A 1hxbA-3slzA:
11.3
1hxbA-3slzA:
27.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3swd UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE


(Escherichia
coli)
PF00275
(EPSP_synthase)
5 GLY A 133
ALA A 134
GLY A  98
ILE A 169
ILE A 136
None
0.88A 1hxbA-3swdA:
undetectable
1hxbA-3swdA:
13.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.38A 1hxbA-3t3cA:
18.6
1hxbA-3t3cA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
017  A 201 (-4.0A)
None
0.67A 1hxbA-3t3cA:
18.6
1hxbA-3t3cA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.61A 1hxbA-3ttpA:
19.6
1hxbA-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
None
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.49A 1hxbA-3ttpA:
19.6
1hxbA-3ttpA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u0o SELENIDE, WATER
DIKINASE


(Escherichia
coli)
PF00586
(AIRS)
PF02769
(AIRS_C)
5 GLY A 213
ALA A 214
ILE A 156
GLY A 155
ILE A  89
None
0.77A 1hxbA-3u0oA:
undetectable
1hxbA-3u0oA:
15.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  48
GLY A  49
PRO A  81
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 ( 4.6A)
017  A 202 (-2.9A)
017  A 202 (-4.0A)
0.47A 1hxbA-3u7sA:
19.9
1hxbA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  47
GLY A  48
GLY A  49
ILE A  50
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 ( 4.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.44A 1hxbA-3u7sA:
19.9
1hxbA-3u7sA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uhj PROBABLE GLYCEROL
DEHYDROGENASE


(Sinorhizobium
meliloti)
PF00465
(Fe-ADH)
5 GLY A 116
VAL A 172
GLY A 266
ILE A 149
ILE A 135
GOL  A 487 (-3.9A)
None
None
None
None
0.78A 1hxbA-3uhjA:
undetectable
1hxbA-3uhjA:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vnp HYPOTHETICAL
CONSERVED PROTEIN


(Geobacillus
kaustophilus)
PF00132
(Hexapep)
5 ALA A 112
ILE A  96
GLY A  97
GLY A 115
ILE A 126
None
0.76A 1hxbA-3vnpA:
undetectable
1hxbA-3vnpA:
18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bhd SERINE
HYDROXYMETHYLTRANSFE
RASE


(Methanocaldococcus
jannaschii)
PF00464
(SHMT)
5 ASP A 196
GLY A 197
ALA A 198
GLY A 233
GLY A 234
None
0.78A 1hxbA-4bhdA:
undetectable
1hxbA-4bhdA:
12.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f32 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE 2


(Burkholderia
vietnamiensis)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A  97
ALA A  96
VAL A   7
ILE A  10
GLY A  11
None
0.76A 1hxbA-4f32A:
undetectable
1hxbA-4f32A:
14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fmg VP1

(Human
polyomavirus 5)
PF00718
(Polyoma_coat)
5 VAL A 311
ILE A 168
GLY A 169
GLY A 170
ILE A  55
None
0.75A 1hxbA-4fmgA:
undetectable
1hxbA-4fmgA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j8f HEAT SHOCK 70 KDA
PROTEIN 1A/1B,
HSC70-INTERACTING
PROTEIN


(Homo sapiens;
Rattus
norvegicus)
PF00012
(HSP70)
5 GLY A 224
ASP A 206
ASP A 199
GLY A 202
GLY A 229
None
PO4  A 603 ( 4.7A)
MG  A 602 ( 3.9A)
ADP  A 601 (-3.4A)
None
0.89A 1hxbA-4j8fA:
undetectable
1hxbA-4j8fA:
11.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jga 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
SYNTHASE 2


(Rickettsia
rickettsii)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 GLY A 276
ALA A 301
ASP A 304
ILE A 273
ILE A 184
None
0.88A 1hxbA-4jgaA:
undetectable
1hxbA-4jgaA:
11.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mzu WXCM-LIKE PROTEIN

(Shewanella
denitrificans)
PF00132
(Hexapep)
PF05523
(FdtA)
5 ALA A 103
ILE A  73
GLY A  74
GLY A 106
ILE A 117
None
0.79A 1hxbA-4mzuA:
undetectable
1hxbA-4mzuA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mzu WXCM-LIKE PROTEIN

(Shewanella
denitrificans)
PF00132
(Hexapep)
PF05523
(FdtA)
5 ALA A 121
ILE A 105
GLY A 106
GLY A 124
ILE A 140
None
0.88A 1hxbA-4mzuA:
undetectable
1hxbA-4mzuA:
15.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.76A 1hxbA-4njvA:
20.2
1hxbA-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.48A 1hxbA-4njvA:
20.2
1hxbA-4njvA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.46A 1hxbA-4njvA:
20.2
1hxbA-4njvA:
86.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p8r GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE,
CYTOSOLIC


(Trypanosoma
brucei)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA A  21
VAL A   5
ILE A 326
ILE A  13
ILE A  29
MG  A 401 (-4.5A)
None
None
NAD  A 400 (-4.3A)
None
0.85A 1hxbA-4p8rA:
undetectable
1hxbA-4p8rA:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qsl PYRUVATE CARBOXYLASE

(Listeria
monocytogenes)
no annotation 5 GLY H 275
ALA H 274
VAL H 311
GLY H  84
ILE H 310
None
0.77A 1hxbA-4qslH:
undetectable
1hxbA-4qslH:
6.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r2b EXTRACELLULAR
SOLUTE-BINDING
PROTEIN FAMILY 1


(Ochrobactrum
anthropi)
PF01547
(SBP_bac_1)
5 GLY A 281
ALA A 280
GLY A  42
GLY A  43
ILE A 260
None
0.66A 1hxbA-4r2bA:
undetectable
1hxbA-4r2bA:
12.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
ILE A 100
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.45A 1hxbA-4ydfA:
13.1
1hxbA-4ydfA:
30.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 ASP A  32
GLY A  34
ALA A  35
ASP A  36
VAL A  39
ILE A 100
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
4B1  A 201 (-4.8A)
0.38A 1hxbA-4ydfA:
13.1
1hxbA-4ydfA:
30.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
None
0.85A 1hxbA-5b18A:
18.1
1hxbA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
None
0.36A 1hxbA-5b18A:
18.1
1hxbA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
None
0.67A 1hxbA-5b18A:
18.1
1hxbA-5b18A:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f42 ACYL-[ACYL-CARRIER-P
ROTEIN]--UDP-N-ACETY
LGLUCOSAMINE
O-ACYLTRANSFERASE


(Francisella
tularensis)
PF00132
(Hexapep)
PF13720
(Acetyltransf_11)
5 ALA A  48
ILE A  32
GLY A  33
GLY A  51
ILE A  62
None
0.89A 1hxbA-5f42A:
undetectable
1hxbA-5f42A:
18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGT
IRON-SULFUR-BINDING
SUBUNIT


(Escherichia
coli)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 GLY A 211
ALA A 212
ASP A 154
GLY A 159
ILE A 216
None
None
None
FES  A 230 (-4.2A)
None
0.80A 1hxbA-5g5gA:
undetectable
1hxbA-5g5gA:
24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ihe DNA POLYMERASE II
SMALL SUBUNIT


(Pyrococcus
abyssi)
PF00149
(Metallophos)
5 GLY A 500
ALA A 530
GLY A 534
GLY A 535
ILE A 458
None
None
None
None
ACT  A 705 (-3.9A)
0.80A 1hxbA-5iheA:
undetectable
1hxbA-5iheA:
12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5itg SORBITOL
DEHYDROGENASE


(Gluconobacter
oxydans)
PF01232
(Mannitol_dh)
PF08125
(Mannitol_dh_C)
5 GLY A  99
ALA A 100
ILE A  28
GLY A  27
PRO A 275
None
0.85A 1hxbA-5itgA:
undetectable
1hxbA-5itgA:
10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jsz CONSERVED
HYPOTHETICAL
MEMBRANE PROTEIN


(Lactobacillus
delbrueckii)
PF12822
(ECF_trnsprt)
5 GLY C  64
ALA C  65
ASP C  68
ILE C  83
GLY C  84
None
0.89A 1hxbA-5jszC:
undetectable
1hxbA-5jszC:
23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5odr METHYL-VIOLOGEN
REDUCING
HYDROGENASE, SUBUNIT
A
METHYL-VIOLOGEN
REDUCING
HYDROGENASE, SUBUNIT
G


(Methanothermococcus
thermolithotrophicus)
PF00374
(NiFeSe_Hases)
PF01058
(Oxidored_q6)
5 GLY F  14
ILE F  60
GLY F  62
ILE E  17
PRO F 374
None
None
None
None
NFU  F 501 (-3.5A)
0.86A 1hxbA-5odrF:
undetectable
1hxbA-5odrF:
11.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
None
0.48A 1hxbA-5t2zA:
20.2
1hxbA-5t2zA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
None
0.45A 1hxbA-5t2zA:
20.2
1hxbA-5t2zA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ux9 CHLORAMPHENICOL
ACETYLTRANSFERASE


(Aliivibrio
fischeri)
PF00132
(Hexapep)
5 GLY A  79
ALA A  80
ILE A 145
GLY A 146
ILE A  76
None
0.80A 1hxbA-5ux9A:
undetectable
1hxbA-5ux9A:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xj1 UNCHARACTERIZED RNA
METHYLTRANSFERASE
SP_1029


(Streptococcus
pneumoniae)
no annotation 5 GLY A 399
ALA A 400
ASP A 401
ILE A 373
ILE A 378
None
0.83A 1hxbA-5xj1A:
undetectable
1hxbA-5xj1A:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ya1 AUTOINDUCER-2 KINASE

(Escherichia
coli)
no annotation 5 GLY A  20
ALA A  19
GLY A 251
GLY A 252
ILE A 171
None
0.70A 1hxbA-5ya1A:
undetectable
1hxbA-5ya1A:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5z0c NEROL DEHYDROGENASE

(Persicaria
minor)
no annotation 5 GLY A 279
VAL A 190
GLY A 194
GLY A 195
ILE A 253
None
None
BME  A 405 ( 4.2A)
BME  A 405 (-3.3A)
None
0.83A 1hxbA-5z0cA:
undetectable
1hxbA-5z0cA:
17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
0.25A 1hxbA-6fivA:
15.5
1hxbA-6fivA:
29.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
None
None
NIU  A 100 ( 3.8A)
None
None
0.61A 1hxbA-6upjA:
18.0
1hxbA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 GLY A  27
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
NIU  A 100 (-4.5A)
None
None
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
0.82A 1hxbA-6upjA:
18.0
1hxbA-6upjA:
48.48